1.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

2.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

3.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

4.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

5.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

6.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

7.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

8.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

9.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

1.

Factors associated with the continuum of care of HIV-infectedpatients in Belgium

2.

Factors associated with the continuum of care of HIV-infectedpatients in Belgium

3.

Factors associated with the continuum of care of HIV-infectedpatients in Belgium

4.

Factors associated with the continuum of care of HIV-infectedpatients in Belgium

5.

Factors associated with the continuum of care of HIV-infectedpatients in Belgium

1.

Human herpes virus 8 infection in kidney transplant patients in Belgium

2.

Human herpes virus 8 infection in kidney transplant patients in Belgium

3.

Human herpes virus 8 infection in kidney transplant patients in Belgium

4.

Human herpes virus 8 infection in kidney transplant patients in Belgium

5.

Human herpes virus 8 infection in kidney transplant patients in Belgium

1.

Measles resurgence in Belgium from January to mid-April 2011 : a preliminary report

2.

Measles resurgence in Belgium from January to mid-April 2011 : a preliminary report

3.

Measles resurgence in Belgium from January to mid-April 2011 : a preliminary report

4.

Measles resurgence in Belgium from January to mid-April 2011 : a preliminary report

5.

Measles resurgence in Belgium from January to mid-April 2011 : a preliminary report

1.

Factors associated with the continuum of care of HIV infected patients in Belgium

2.

Factors associated with the continuum of care of HIV infected patients in Belgium

1.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

2.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

3.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

4.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

5.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

6.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

7.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

8.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

9.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

1.

Factors associated with the continuum of care of HIV‐infected patients in Belgium

2.

Factors associated with the continuum of care of HIV‐infected patients in Belgium